Endometrial hyperplasia is categorized into endometrial hyperplasia without atypical hyperplasia and endometrial atypical hyperplasia. According to the different degrees and types of hyperplasia of patients, they can choose observation, medication or surgery. 1. Endometrial hyperplasia without atypical hyperplasia has a low risk of developing into endometrial cancer within 20 years and can be observed and followed up. However, for patients with high risk of long-term abnormal uterine bleeding, obesity, and use of progesterone receptor antagonists. Progesterone should be used for a long period of time under the guidance of gynecologist to control the symptoms and prevent endometrial malignancy, and regular follow-up is required. 2. For atypical endometrial hyperplasia, the choice of surgical or pharmacologic treatment depends on the need for fertility and age. Total hysterectomy is preferred for those without fertility needs, and the choice of whether to remove both ovaries should be individualized. However, it is recommended to remove both fallopian tubes to minimize the risk of ovarian cancer in the future. Patients with fertility requirements or those who cannot tolerate surgery may choose progestin drug therapy under the guidance of gynecologists. For women in their reproductive years, endometrial hyperplasia is often characterized by menstrual abnormalities, such as irregular uterine bleeding, prolonged or shortened menstrual cycles, prolonged menstrual periods, and heavy or light menstrual flow. Once the above situations occur, you should consult a doctor for early diagnosis and treatment.